ArticleCancer biology & therapy2016

Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer.

Wataru Nakajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.